ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global GLP Analogs Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-5M10606
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global and United States GLP Analogs Market Report Forecast 2022 2028
BUY CHAPTERS

Global GLP Analogs Market Research Report 2025

Code: QYRE-Auto-5M10606
Report
July 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novo Nordisk
Astrazeneca plc
Eli Lily
GSK
Sanofi
Bristol–Myers Squibb
Amylin

GLP Analogs Market Size

The global market for GLP Analogs was valued at US$ 5931 million in the year 2024 and is projected to reach a revised size of US$ 7931 million by 2031, growing at a CAGR of 4.3% during the forecast period.

GLP Analogs Market

GLP Analogs Market

Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
The Glucagon-like peptide 1 (GLP-1) market is driven by the increasing prevalence of diabetes and the growing demand for effective and innovative diabetes treatments. GLP-1 is a hormone that plays a crucial role in regulating blood sugar levels and is used in the treatment of type 2 diabetes. The rise in the number of diabetic patients and the need for better glycemic control contribute to market growth as GLP-1-based therapies offer significant benefits, including glucose-lowering effects and weight management. Moreover, advancements in GLP-1 analog formulations, such as long-acting and once-weekly options, have improved patient compliance and treatment outcomes. However, the market also faces challenges, including the cost of GLP-1 treatments and the need for further research to optimize dosing and combination therapies. Additionally, addressing the barriers to GLP-1 adoption, such as injection-related fears, can pose obstacles for broader market penetration. To succeed, companies must focus on research and development to offer innovative and cost-effective GLP-1 therapies, collaborate with healthcare providers to optimize treatment regimens, and address the challenges to meet the increasing demand for effective and well-tolerated diabetes treatments based on GLP-1.

Report Scope

This report aims to provide a comprehensive presentation of the global market for GLP Analogs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GLP Analogs.
The GLP Analogs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GLP Analogs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GLP Analogs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of GLP Analogs Market Report

Report Metric Details
Report Name GLP Analogs Market
Accounted market size in year US$ 5931 million
Forecasted market size in 2031 US$ 7931 million
CAGR 4.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novo Nordisk, AstraZeneca, Eli Lily, GSK, Sanofi, Bristol-Myers Squibb, Amylin
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of GLP Analogs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of GLP Analogs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is GLP Analogs Market growing?

Ans: The GLP Analogs Market witnessing a CAGR of 4.3% during the forecast period 2025-2031.

What is the GLP Analogs Market size in 2031?

Ans: The GLP Analogs Market size in 2031 will be US$ 7931 million.

Who are the main players in the GLP Analogs Market report?

Ans: The main players in the GLP Analogs Market are Novo Nordisk, AstraZeneca, Eli Lily, GSK, Sanofi, Bristol-Myers Squibb, Amylin

What are the Application segmentation covered in the GLP Analogs Market report?

Ans: The Applications covered in the GLP Analogs Market report are Hospital, Pharmacy, Other

What are the Type segmentation covered in the GLP Analogs Market report?

Ans: The Types covered in the GLP Analogs Market report are Exenatied, Liraglutide, Lixisenatide, Albiglutide, Dulaglutide

Recommended Reports

GLP-1 Drugs & Therapy

Peptide & Diabetes Markets

Liraglutide & Related GLPs

1 GLP Analogs Market Overview
1.1 Product Definition
1.2 GLP Analogs by Type
1.2.1 Global GLP Analogs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Exenatied
1.2.3 Liraglutide
1.2.4 Lixisenatide
1.2.5 Albiglutide
1.2.6 Dulaglutide
1.3 GLP Analogs by Application
1.3.1 Global GLP Analogs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global GLP Analogs Market Size Estimates and Forecasts
1.4.1 Global GLP Analogs Revenue 2020-2031
1.4.2 Global GLP Analogs Sales 2020-2031
1.4.3 Global GLP Analogs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 GLP Analogs Market Competition by Manufacturers
2.1 Global GLP Analogs Sales Market Share by Manufacturers (2020-2025)
2.2 Global GLP Analogs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global GLP Analogs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of GLP Analogs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GLP Analogs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GLP Analogs, Product Type & Application
2.7 Global Key Manufacturers of GLP Analogs, Date of Enter into This Industry
2.8 Global GLP Analogs Market Competitive Situation and Trends
2.8.1 Global GLP Analogs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest GLP Analogs Players Market Share by Revenue
2.8.3 Global GLP Analogs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GLP Analogs Market Scenario by Region
3.1 Global GLP Analogs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global GLP Analogs Sales by Region: 2020-2031
3.2.1 Global GLP Analogs Sales by Region: 2020-2025
3.2.2 Global GLP Analogs Sales by Region: 2026-2031
3.3 Global GLP Analogs Revenue by Region: 2020-2031
3.3.1 Global GLP Analogs Revenue by Region: 2020-2025
3.3.2 Global GLP Analogs Revenue by Region: 2026-2031
3.4 North America GLP Analogs Market Facts & Figures by Country
3.4.1 North America GLP Analogs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America GLP Analogs Sales by Country (2020-2031)
3.4.3 North America GLP Analogs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe GLP Analogs Market Facts & Figures by Country
3.5.1 Europe GLP Analogs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe GLP Analogs Sales by Country (2020-2031)
3.5.3 Europe GLP Analogs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GLP Analogs Market Facts & Figures by Region
3.6.1 Asia Pacific GLP Analogs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific GLP Analogs Sales by Region (2020-2031)
3.6.3 Asia Pacific GLP Analogs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America GLP Analogs Market Facts & Figures by Country
3.7.1 Latin America GLP Analogs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America GLP Analogs Sales by Country (2020-2031)
3.7.3 Latin America GLP Analogs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa GLP Analogs Market Facts & Figures by Country
3.8.1 Middle East and Africa GLP Analogs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa GLP Analogs Sales by Country (2020-2031)
3.8.3 Middle East and Africa GLP Analogs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GLP Analogs Sales by Type (2020-2031)
4.1.1 Global GLP Analogs Sales by Type (2020-2025)
4.1.2 Global GLP Analogs Sales by Type (2026-2031)
4.1.3 Global GLP Analogs Sales Market Share by Type (2020-2031)
4.2 Global GLP Analogs Revenue by Type (2020-2031)
4.2.1 Global GLP Analogs Revenue by Type (2020-2025)
4.2.2 Global GLP Analogs Revenue by Type (2026-2031)
4.2.3 Global GLP Analogs Revenue Market Share by Type (2020-2031)
4.3 Global GLP Analogs Price by Type (2020-2031)
5 Segment by Application
5.1 Global GLP Analogs Sales by Application (2020-2031)
5.1.1 Global GLP Analogs Sales by Application (2020-2025)
5.1.2 Global GLP Analogs Sales by Application (2026-2031)
5.1.3 Global GLP Analogs Sales Market Share by Application (2020-2031)
5.2 Global GLP Analogs Revenue by Application (2020-2031)
5.2.1 Global GLP Analogs Revenue by Application (2020-2025)
5.2.2 Global GLP Analogs Revenue by Application (2026-2031)
5.2.3 Global GLP Analogs Revenue Market Share by Application (2020-2031)
5.3 Global GLP Analogs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk GLP Analogs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk GLP Analogs Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca GLP Analogs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AstraZeneca GLP Analogs Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Eli Lily
6.3.1 Eli Lily Company Information
6.3.2 Eli Lily Description and Business Overview
6.3.3 Eli Lily GLP Analogs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli Lily GLP Analogs Product Portfolio
6.3.5 Eli Lily Recent Developments/Updates
6.4 GSK
6.4.1 GSK Company Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK GLP Analogs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GSK GLP Analogs Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Company Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi GLP Analogs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sanofi GLP Analogs Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Company Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb GLP Analogs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bristol-Myers Squibb GLP Analogs Product Portfolio
6.6.5 Bristol-Myers Squibb Recent Developments/Updates
6.7 Amylin
6.7.1 Amylin Company Information
6.7.2 Amylin Description and Business Overview
6.7.3 Amylin GLP Analogs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Amylin GLP Analogs Product Portfolio
6.7.5 Amylin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GLP Analogs Industry Chain Analysis
7.2 GLP Analogs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GLP Analogs Production Mode & Process Analysis
7.4 GLP Analogs Sales and Marketing
7.4.1 GLP Analogs Sales Channels
7.4.2 GLP Analogs Distributors
7.5 GLP Analogs Customer Analysis
8 GLP Analogs Market Dynamics
8.1 GLP Analogs Industry Trends
8.2 GLP Analogs Market Drivers
8.3 GLP Analogs Market Challenges
8.4 GLP Analogs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novo Nordisk
Astrazeneca plc
Eli Lily
GSK
Sanofi
Bristol–Myers Squibb
Amylin
List of Tables
 Table 1. Global GLP Analogs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global GLP Analogs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global GLP Analogs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global GLP Analogs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global GLP Analogs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global GLP Analogs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global GLP Analogs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market GLP Analogs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of GLP Analogs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of GLP Analogs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of GLP Analogs, Product Type & Application
 Table 12. Global Key Manufacturers of GLP Analogs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global GLP Analogs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP Analogs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global GLP Analogs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global GLP Analogs Sales by Region (2020-2025) & (K Units)
 Table 18. Global GLP Analogs Sales Market Share by Region (2020-2025)
 Table 19. Global GLP Analogs Sales by Region (2026-2031) & (K Units)
 Table 20. Global GLP Analogs Sales Market Share by Region (2026-2031)
 Table 21. Global GLP Analogs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global GLP Analogs Revenue Market Share by Region (2020-2025)
 Table 23. Global GLP Analogs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global GLP Analogs Revenue Market Share by Region (2026-2031)
 Table 25. North America GLP Analogs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America GLP Analogs Sales by Country (2020-2025) & (K Units)
 Table 27. North America GLP Analogs Sales by Country (2026-2031) & (K Units)
 Table 28. North America GLP Analogs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America GLP Analogs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe GLP Analogs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe GLP Analogs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe GLP Analogs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe GLP Analogs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe GLP Analogs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific GLP Analogs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific GLP Analogs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific GLP Analogs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific GLP Analogs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific GLP Analogs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America GLP Analogs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America GLP Analogs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America GLP Analogs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America GLP Analogs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America GLP Analogs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa GLP Analogs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa GLP Analogs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa GLP Analogs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa GLP Analogs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa GLP Analogs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global GLP Analogs Sales (K Units) by Type (2020-2025)
 Table 51. Global GLP Analogs Sales (K Units) by Type (2026-2031)
 Table 52. Global GLP Analogs Sales Market Share by Type (2020-2025)
 Table 53. Global GLP Analogs Sales Market Share by Type (2026-2031)
 Table 54. Global GLP Analogs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global GLP Analogs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global GLP Analogs Revenue Market Share by Type (2020-2025)
 Table 57. Global GLP Analogs Revenue Market Share by Type (2026-2031)
 Table 58. Global GLP Analogs Price (USD/Unit) by Type (2020-2025)
 Table 59. Global GLP Analogs Price (USD/Unit) by Type (2026-2031)
 Table 60. Global GLP Analogs Sales (K Units) by Application (2020-2025)
 Table 61. Global GLP Analogs Sales (K Units) by Application (2026-2031)
 Table 62. Global GLP Analogs Sales Market Share by Application (2020-2025)
 Table 63. Global GLP Analogs Sales Market Share by Application (2026-2031)
 Table 64. Global GLP Analogs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global GLP Analogs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global GLP Analogs Revenue Market Share by Application (2020-2025)
 Table 67. Global GLP Analogs Revenue Market Share by Application (2026-2031)
 Table 68. Global GLP Analogs Price (USD/Unit) by Application (2020-2025)
 Table 69. Global GLP Analogs Price (USD/Unit) by Application (2026-2031)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Novo Nordisk GLP Analogs Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. AstraZeneca Company Information
 Table 76. AstraZeneca Description and Business Overview
 Table 77. AstraZeneca GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. AstraZeneca GLP Analogs Product
 Table 79. AstraZeneca Recent Developments/Updates
 Table 80. Eli Lily Company Information
 Table 81. Eli Lily Description and Business Overview
 Table 82. Eli Lily GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Eli Lily GLP Analogs Product
 Table 84. Eli Lily Recent Developments/Updates
 Table 85. GSK Company Information
 Table 86. GSK Description and Business Overview
 Table 87. GSK GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. GSK GLP Analogs Product
 Table 89. GSK Recent Developments/Updates
 Table 90. Sanofi Company Information
 Table 91. Sanofi Description and Business Overview
 Table 92. Sanofi GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Sanofi GLP Analogs Product
 Table 94. Sanofi Recent Developments/Updates
 Table 95. Bristol-Myers Squibb Company Information
 Table 96. Bristol-Myers Squibb Description and Business Overview
 Table 97. Bristol-Myers Squibb GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Bristol-Myers Squibb GLP Analogs Product
 Table 99. Bristol-Myers Squibb Recent Developments/Updates
 Table 100. Amylin Company Information
 Table 101. Amylin Description and Business Overview
 Table 102. Amylin GLP Analogs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Amylin GLP Analogs Product
 Table 104. Amylin Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. GLP Analogs Distributors List
 Table 108. GLP Analogs Customers List
 Table 109. GLP Analogs Market Trends
 Table 110. GLP Analogs Market Drivers
 Table 111. GLP Analogs Market Challenges
 Table 112. GLP Analogs Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of GLP Analogs
 Figure 2. Global GLP Analogs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global GLP Analogs Market Share by Type: 2024 & 2031
 Figure 4. Exenatied Product Picture
 Figure 5. Liraglutide Product Picture
 Figure 6. Lixisenatide Product Picture
 Figure 7. Albiglutide Product Picture
 Figure 8. Dulaglutide Product Picture
 Figure 9. Global GLP Analogs Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global GLP Analogs Market Share by Application: 2024 & 2031
 Figure 11. Hospital
 Figure 12. Pharmacy
 Figure 13. Other
 Figure 14. Global GLP Analogs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global GLP Analogs Market Size (2020-2031) & (US$ Million)
 Figure 16. Global GLP Analogs Sales (2020-2031) & (K Units)
 Figure 17. Global GLP Analogs Average Price (USD/Unit) & (2020-2031)
 Figure 18. GLP Analogs Report Years Considered
 Figure 19. GLP Analogs Sales Share by Manufacturers in 2024
 Figure 20. Global GLP Analogs Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest GLP Analogs Players: Market Share by Revenue in GLP Analogs in 2024
 Figure 22. GLP Analogs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global GLP Analogs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America GLP Analogs Sales Market Share by Country (2020-2031)
 Figure 25. North America GLP Analogs Revenue Market Share by Country (2020-2031)
 Figure 26. United States GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe GLP Analogs Sales Market Share by Country (2020-2031)
 Figure 29. Europe GLP Analogs Revenue Market Share by Country (2020-2031)
 Figure 30. Germany GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific GLP Analogs Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific GLP Analogs Revenue Market Share by Region (2020-2031)
 Figure 37. China GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America GLP Analogs Sales Market Share by Country (2020-2031)
 Figure 47. Latin America GLP Analogs Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa GLP Analogs Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa GLP Analogs Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE GLP Analogs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of GLP Analogs by Type (2020-2031)
 Figure 57. Global Revenue Market Share of GLP Analogs by Type (2020-2031)
 Figure 58. Global GLP Analogs Price (USD/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of GLP Analogs by Application (2020-2031)
 Figure 60. Global Revenue Market Share of GLP Analogs by Application (2020-2031)
 Figure 61. Global GLP Analogs Price (USD/Unit) by Application (2020-2031)
 Figure 62. GLP Analogs Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Glucagon Like Peptide 1 GLP 1 Agonists Market Research Report 2025
Global Antidiabetic Glucagon like Peptide 1 Agonists Market Research Report 2025
Global Glucagon like peptide 1 GLP 1 based Therapies Market Research Report 2025
Global GLP 1 Receptor Agonist Drugs Market Research Report 2024
Global Oral GLP 1 Agonist Market Research Report 2024
Global GLP 1 Agonists for Obesity Market Research Report 2024
GLP 1 Analogues Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Agonist Injection Market Research Report 2024
Global GLP 1 Agonists for the Treatment of both Diabetes and Obesity Market Research Report 2024
GLP 1 for Weight Loss Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Receptor Antagonist Market Research Report 2024
Global GLP 1 Drugs Market Research Report 2024
Global GLP 1RA Therapy Market Research Report 2024
Global GLP 1 Drug Peptide API Market Research Report 2024
Global GLP 1 Weight Loss Pill Market Research Report 2024
Global GLP 1 Weight Loss Drug Market Research Report 2024
Liraglutide Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GIP 1 Receptor Agonist Market Research Report 2024
Global Liraglutide for The Treatment of Diabetes and Obesity Market Research Report 2024
Global GLP 1 Injection Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions